Authors: Braybrooke, JP Vallis, KA Houlbrook, S Rockett, H Ellmen, J Anttila, M Ganesan, TS Harris, AL Talbot, DC

Citation: Jp. Braybrooke et al., Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine, CANC CHEMOT, 46(1), 2000, pp. 27-34

Authors: Ellmen, J Werner, D Hakulinen, P Keiling, R Fargeot, P Falkson, G Bezwoda, WR

Citation: J. Ellmen et al., Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients, CANC CHEMOT, 45(5), 2000, pp. 402-408

Authors: Maenpaa, J Ellmen, J Pasanen, T Kaukonen, M

Citation: J. Maenpaa et al., Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth, J NAT CANC, 91(11), 1999, pp. 972-973

Authors: Pyrhonen, S Ellmen, J Vuorinen, J Gershanovich, M Tominaga, T Kaufmann, M Hayes, DF

Citation: S. Pyrhonen et al., Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer, BREAST CANC, 56(2), 1999, pp. 133-143